Capricor Therapeutics Interest Expense 2011-2026 | CAPR

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Capricor Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	399 K	345 K	249 K	201 K	58.1 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
399 K	58.1 K	250 K

Quarterly Interest Expense Capricor Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108 K	106 K	105 K	-	98.7 K	76.9 K	66.1 K	-	61.7 K	61.7 K	61.7 K	-	60.1 K	54.7 K	25.3 K	-	23.4 K	6.21 K	3.71 K	-	-	-	-	-	-	-1.34 K	-168

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
108 K	-1.34 K	54 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	13.2 M	$ 2.13	-12.55 %	$ 219 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
BioCardia BCDA	3 K	$ 1.37	6.2 %	$ 29 M	USA
Black Diamond Therapeutics BDTX	6.92 M	$ 2.4	-2.83 %	$ 132 M	USA
BioLineRx Ltd. BLRX	9.07 M	$ 2.8	-1.06 %	$ 908 M	Israel
I-Mab IMAB	722 K	-	-	$ 866 M	China
BioXcel Therapeutics BTAI	20.2 M	$ 1.64	-1.8 %	$ 4.16 M	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
BeyondSpring BYSI	17 K	$ 1.44	6.3 %	$ 58.1 M	USA
AbCellera Biologics ABCL	-2.71 M	$ 3.7	2.49 %	$ 1.11 B	Canada
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Codexis CDXS	-10.4 M	$ 1.05	3.47 %	$ 77.1 M	USA
Cerus Corporation CERS	1.98 M	$ 2.6	1.56 %	$ 480 M	USA
Certara CERT	6.34 M	$ 7.17	1.27 %	$ 1.15 B	USA
Cullinan Management CGEM	-199 K	$ 15.91	2.65 %	$ 931 M	USA
Compugen Ltd. CGEN	281 K	$ 2.28	25.97 %	$ 204 M	Israel
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Coherus BioSciences CHRS	40.5 M	$ 1.66	-0.9 %	$ 156 M	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	371 K	$ 3.88	-	$ 116 M	France
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
CNS Pharmaceuticals CNSP	7.03 K	$ 3.1	-0.44 %	$ 1.18 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Cocrystal Pharma COCP	2 K	$ 1.02	-0.97 %	$ 10.4 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Collegium Pharmaceutical COLL	21 M	$ 42.0	0.79 %	$ 1.33 B	USA
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA